| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.86.1.56 |
| P953 | full work available at URL | https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.86.1.56 |
| P698 | PubMed publication ID | 1617790 |
| P2093 | author name string | R. W. Nesto | |
| D. A. Brezinski | |||
| C. N. Serhan | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspirin | Q18216 |
| coronary balloon angioplasty | Q67272498 | ||
| coronary vessel | Q67315798 | ||
| Cardiology and cardiovascular medicine | Q96320350 | ||
| angioplasty | Q539795 | ||
| P304 | page(s) | 56-63 | |
| P577 | publication date | 1992-07-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy | |
| P478 | volume | 86 |
| Q33814296 | A novel workflow combining plaque imaging, plaque and plasma proteomics identifies biomarkers of human coronary atherosclerotic plaque disruption |
| Q28211367 | A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution |
| Q57240788 | Agonist-induced lipoxin A4 generation: Detection by a novel lipoxin A4-ELISA |
| Q30234292 | Alleviating Promotion of Inflammation and Cancer Induced by Nonsteroidal Anti-Inflammatory Drugs |
| Q37282266 | An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques |
| Q37071968 | Anti-inflammatory and proresolving lipid mediators |
| Q40457712 | Antithrombotic and thrombolytic therapy in patients undergoing coronary artery interventions: A review |
| Q28165894 | Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease |
| Q24563341 | Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions |
| Q43076924 | Aspirin-triggered 15-epi-lipoxin A₄ signals through FPR2/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation |
| Q89493552 | Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E-/- mice |
| Q34032060 | Association of ALOX5AP with ischemic stroke in eastern Chinese |
| Q36879456 | Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators |
| Q38681468 | Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy |
| Q64120892 | Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype? |
| Q33583270 | Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary disease |
| Q41939396 | Correlation of leukocyte adhesiveness, adhesion molecule expression and leukocyte-induced contraction following balloon angioplasty. |
| Q47794645 | Determinants of rebound thrombin activity after cessation of heparin in patients undergoing coronary interventions |
| Q72109690 | Dietary n − 3 polyunsaturated fatty acids modify Syrian hamster platelet and macrophage phospholipid fatty acyl composition and eicosanoid synthesis: a controlled study |
| Q49379499 | Differential action of polyunsaturated fatty acids and eicosanoids on bleomycin-induced cytotoxicity to neuroblastoma cells and lymphocytes |
| Q24543690 | Differential induction of BLT receptor expression on human endothelial cells by lipopolysaccharide, cytokines, and leukotriene B4 |
| Q45276638 | Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites. |
| Q35490693 | High sensitivity quantitative lipidomics analysis of fatty acids in biological samples by gas chromatography-mass spectrometry |
| Q24306317 | Identification, cloning, and functional characterization of a murine lipoxin A4 receptor homologue gene |
| Q83316169 | Impact of selenium on the leukotriene B4 synthesis pathway during isoproterenol-induced myocardial infarction in experimental rats |
| Q38625480 | Inflammation and pro-resolution inflammation after hepatobiliary surgery |
| Q37284714 | Inflammatory mediators in saliva associated with arterial stiffness and subclinical atherosclerosis. |
| Q35770168 | Inflammatory resolution: new opportunities for drug discovery |
| Q71420703 | Intimal injury in a transiently occluded coronary artery increases myocardial necrosis. Effect of aspirin |
| Q33637566 | Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder. |
| Q27025129 | Leukotrienes as modifiers of preclinical atherosclerosis? |
| Q35068536 | Lipoxin A4 mediates aortic contraction via RHOA/RHO kinase, endothelial dysfunction and reactive oxygen species |
| Q34110113 | Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers |
| Q59328896 | Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease |
| Q24321473 | Lipoxin synthase activity of human platelet 12-lipoxygenase |
| Q28194218 | Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution |
| Q27863448 | Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? |
| Q37604436 | Lipoxins: resolutionary road |
| Q37964882 | Paradigm shift in the pharmacological management of periodontal diseases |
| Q35027103 | Platelets, neutrophils, and vasoconstriction after arterial injury by angioplasty in pigs: effects of MK-886, a leukotriene biosynthesis inhibitor |
| Q90735171 | Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases |
| Q42367800 | Proresolving Lipid Mediators Restore Balance to the Vulnerable Plaque |
| Q92678361 | Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review |
| Q45064553 | Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications |
| Q34315513 | Resolvin E1 regulates adenosine diphosphate activation of human platelets |
| Q64084919 | Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis |
| Q39160278 | Specialized pro-resolving mediators in cardiovascular diseases |
| Q39197238 | Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors |
| Q56944340 | The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke |
| Q71705217 | Transcellular biosynthesis of lipoxin A4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis |
| Q39088075 | Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms |
| Q37259842 | Urinary leukotriene E4 is associated with renal function but not with endothelial function in type 2 diabetes. |
Search more.